Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized Open Label Study Evaluating the Role of Oral Antibiotics in an Aim to Eradicate Carrier State of Carbapenem- Resistant Klebsiella Pneumonia (KPC).

NCT01266499 is registered in ClinicalTrials.gov with Rambam Health Care Campus as lead sponsor.

NCT NCT01266499
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01266499 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized Open Label Study Evaluating the Role of Oral Antibiotics in an Aim to Eradicate Carrier State of Carbapenem- Resistant Klebsiella Pneumonia (KPC).
Lead sponsor
Rambam Health Care Campus
Phase
Not applicable
Overall status
Completed
Start date
July 31, 2009
Completion date
January 31, 2012
Enrollment
200 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

klebsiella pneumoniae carbapenemase resistant associated bacteremia or pneumonia